NCT02832648View on ClinicalTrials.gov

Selenium for Musculoskeletal Health

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Osteoporosis
Interventions
DIETARY_SUPPLEMENT

selenase (selenium)

Selenase (Biosyn, Germany) Sodium selenite pentahydrate

Trial Locations (1)

S10 2JF

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

University of Sheffield

OTHER

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT02832648 - Selenium for Musculoskeletal Health | Biotech Hunter | Biotech Hunter